25
May 2026
Gay dating apps during travel bring connection and emotional fatigue
New research shows that gay dating apps during travel can bring excitement and connection - but also emotional exhaustion, catfishing, and vulnerability.

Increasing and changing demands concerning the health of populations and limited resources require our health care organizations and systems to rethink their sustainability. To achieve objectives, such as improved healthcare quality, health outcomes, efficiency and staff satisfaction, we support our clients in making evidence-based decisions. With tailor-made research projects, we provide insights into what works, for whom, at what cost, and under what circumstances. Based on your challenge, we can support you by:
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
25
May 2026
New research shows that gay dating apps during travel can bring excitement and connection - but also emotional exhaustion, catfishing, and vulnerability.
25
May 2026
Changes in land-use across Southeast Asia over the past 15 years are worsening air quality and contributing to thousands of excess deaths each year, according to a study led by researchers from Nanyang Technological University, Singapore (NTU Singapore).
25
May 2026
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial.
25
May 2026
Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder with a complex pathogenesis. Although epitranscriptomic modifications such as N6-methyladenosine (m6A) have been implicated in NAFLD, the role of N1-methyladenosine (m1A) and its regulators is largely unexplored.